Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-01

Clinical Trial Update: Study to Investigate Effect of Sildenafil on Clitoral Engorgement as Measured by Magnetic Resonance Imaging (MRI) in Pre-menopausal Women With Female Sexual Arousal Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating sildenafil for clitoral engorgement in premenopausal women with Female Sexual Arousal Disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Female Sexual Arousal Disorder | Phase 2 | Status: COMPLETED